The global market for Fexofenadine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker

North American market for Fexofenadine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Fexofenadine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Fexofenadine include Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, Titan Pharma, AFCL, Synkromax, Farmhispania, Gen Pharma, Admiron Life Sciences Private Limited, JRC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fexofenadine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fexofenadine.

The Fexofenadine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fexofenadine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fexofenadine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fexofenadine Market Report

Report Metric	Details
Report Name	Fexofenadine Market
Segment by Type	Purity:98% Purity:Above 98%
Segment by Application	Hay Fever Treatment Urticaria Treatment
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, Titan Pharma, AFCL, Synkromax, Farmhispania, Gen Pharma, Admiron Life Sciences Private Limited, JRC, Archerchem, Sibram, Sumitomo Chemical, Panchsheel, CAMEO HEALTH CARE, CEPiA-Sanofi, Va Sudha Pharma Chem Limited, VPL Chemicals, Zhejiang Excel Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fexofenadine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fexofenadine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fexofenadine Market report?

Ans: The main players in the Fexofenadine Market are Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, Titan Pharma, AFCL, Synkromax, Farmhispania, Gen Pharma, Admiron Life Sciences Private Limited, JRC, Archerchem, Sibram, Sumitomo Chemical, Panchsheel, CAMEO HEALTH CARE, CEPiA-Sanofi, Va Sudha Pharma Chem Limited, VPL Chemicals, Zhejiang Excel Pharmaceutical

What are the Application segmentation covered in the Fexofenadine Market report?

Ans: The Applications covered in the Fexofenadine Market report are Hay Fever Treatment, Urticaria Treatment

What are the Type segmentation covered in the Fexofenadine Market report?

Ans: The Types covered in the Fexofenadine Market report are Purity:98%, Purity:Above 98%

1 Fexofenadine Market Overview

1.1 Product Definition

1.2 Fexofenadine by Type

1.2.1 Global Fexofenadine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Purity:98%

1.2.3 Purity:Above 98%

1.3 Fexofenadine by Application

1.3.1 Global Fexofenadine Market Value by Application (2024 VS 2031)

1.3.2 Hay Fever Treatment

1.3.3 Urticaria Treatment

1.4 Global Fexofenadine Market Size Estimates and Forecasts

1.4.1 Global Fexofenadine Revenue 2020-2031

1.4.2 Global Fexofenadine Sales 2020-2031

1.4.3 Global Fexofenadine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Fexofenadine Market Competition by Manufacturers

2.1 Global Fexofenadine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Fexofenadine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Fexofenadine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Fexofenadine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Fexofenadine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Fexofenadine, Product Type & Application

2.7 Global Key Manufacturers of Fexofenadine, Date of Enter into This Industry

2.8 Global Fexofenadine Market Competitive Situation and Trends

2.8.1 Global Fexofenadine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Fexofenadine Players Market Share by Revenue

2.8.3 Global Fexofenadine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Fexofenadine Market Scenario by Region

3.1 Global Fexofenadine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Fexofenadine Sales by Region: 2020-2031

3.2.1 Global Fexofenadine Sales by Region: 2020-2025

3.2.2 Global Fexofenadine Sales by Region: 2026-2031

3.3 Global Fexofenadine Revenue by Region: 2020-2031

3.3.1 Global Fexofenadine Revenue by Region: 2020-2025

3.3.2 Global Fexofenadine Revenue by Region: 2026-2031

3.4 North America Fexofenadine Market Facts & Figures by Country

3.4.1 North America Fexofenadine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Fexofenadine Sales by Country (2020-2031)

3.4.3 North America Fexofenadine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Fexofenadine Market Facts & Figures by Country

3.5.1 Europe Fexofenadine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Fexofenadine Sales by Country (2020-2031)

3.5.3 Europe Fexofenadine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Fexofenadine Market Facts & Figures by Region

3.6.1 Asia Pacific Fexofenadine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Fexofenadine Sales by Region (2020-2031)

3.6.3 Asia Pacific Fexofenadine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Fexofenadine Market Facts & Figures by Country

3.7.1 Latin America Fexofenadine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Fexofenadine Sales by Country (2020-2031)

3.7.3 Latin America Fexofenadine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Fexofenadine Market Facts & Figures by Country

3.8.1 Middle East and Africa Fexofenadine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Fexofenadine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Fexofenadine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Fexofenadine Sales by Type (2020-2031)

4.1.1 Global Fexofenadine Sales by Type (2020-2025)

4.1.2 Global Fexofenadine Sales by Type (2026-2031)

4.1.3 Global Fexofenadine Sales Market Share by Type (2020-2031)

4.2 Global Fexofenadine Revenue by Type (2020-2031)

4.2.1 Global Fexofenadine Revenue by Type (2020-2025)

4.2.2 Global Fexofenadine Revenue by Type (2026-2031)

4.2.3 Global Fexofenadine Revenue Market Share by Type (2020-2031)

4.3 Global Fexofenadine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Fexofenadine Sales by Application (2020-2031)

5.1.1 Global Fexofenadine Sales by Application (2020-2025)

5.1.2 Global Fexofenadine Sales by Application (2026-2031)

5.1.3 Global Fexofenadine Sales Market Share by Application (2020-2031)

5.2 Global Fexofenadine Revenue by Application (2020-2031)

5.2.1 Global Fexofenadine Revenue by Application (2020-2025)

5.2.2 Global Fexofenadine Revenue by Application (2026-2031)

5.2.3 Global Fexofenadine Revenue Market Share by Application (2020-2031)

5.3 Global Fexofenadine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Viruj Pharma

6.1.1 Viruj Pharma Company Information

6.1.2 Viruj Pharma Description and Business Overview

6.1.3 Viruj Pharma Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Viruj Pharma Fexofenadine Product Portfolio

6.1.5 Viruj Pharma Recent Developments/Updates

6.2 Cemex Pharma

6.2.1 Cemex Pharma Company Information

6.2.2 Cemex Pharma Description and Business Overview

6.2.3 Cemex Pharma Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Cemex Pharma Fexofenadine Product Portfolio

6.2.5 Cemex Pharma Recent Developments/Updates

6.3 Smaart Pharmaceutticals

6.3.1 Smaart Pharmaceutticals Company Information

6.3.2 Smaart Pharmaceutticals Description and Business Overview

6.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Smaart Pharmaceutticals Fexofenadine Product Portfolio

6.3.5 Smaart Pharmaceutticals Recent Developments/Updates

6.4 Titan Pharma

6.4.1 Titan Pharma Company Information

6.4.2 Titan Pharma Description and Business Overview

6.4.3 Titan Pharma Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Titan Pharma Fexofenadine Product Portfolio

6.4.5 Titan Pharma Recent Developments/Updates

6.5 AFCL

6.5.1 AFCL Company Information

6.5.2 AFCL Description and Business Overview

6.5.3 AFCL Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AFCL Fexofenadine Product Portfolio

6.5.5 AFCL Recent Developments/Updates

6.6 Synkromax

6.6.1 Synkromax Company Information

6.6.2 Synkromax Description and Business Overview

6.6.3 Synkromax Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Synkromax Fexofenadine Product Portfolio

6.6.5 Synkromax Recent Developments/Updates

6.7 Farmhispania

6.7.1 Farmhispania Company Information

6.7.2 Farmhispania Description and Business Overview

6.7.3 Farmhispania Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Farmhispania Fexofenadine Product Portfolio

6.7.5 Farmhispania Recent Developments/Updates

6.8 Gen Pharma

6.8.1 Gen Pharma Company Information

6.8.2 Gen Pharma Description and Business Overview

6.8.3 Gen Pharma Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Gen Pharma Fexofenadine Product Portfolio

6.8.5 Gen Pharma Recent Developments/Updates

6.9 Admiron Life Sciences Private Limited

6.9.1 Admiron Life Sciences Private Limited Company Information

6.9.2 Admiron Life Sciences Private Limited Description and Business Overview

6.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Admiron Life Sciences Private Limited Fexofenadine Product Portfolio

6.9.5 Admiron Life Sciences Private Limited Recent Developments/Updates

6.10 JRC

6.10.1 JRC Company Information

6.10.2 JRC Description and Business Overview

6.10.3 JRC Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 JRC Fexofenadine Product Portfolio

6.10.5 JRC Recent Developments/Updates

6.11 Archerchem

6.11.1 Archerchem Company Information

6.11.2 Archerchem Description and Business Overview

6.11.3 Archerchem Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Archerchem Fexofenadine Product Portfolio

6.11.5 Archerchem Recent Developments/Updates

6.12 Sibram

6.12.1 Sibram Company Information

6.12.2 Sibram Description and Business Overview

6.12.3 Sibram Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Sibram Fexofenadine Product Portfolio

6.12.5 Sibram Recent Developments/Updates

6.13 Sumitomo Chemical

6.13.1 Sumitomo Chemical Company Information

6.13.2 Sumitomo Chemical Description and Business Overview

6.13.3 Sumitomo Chemical Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Sumitomo Chemical Fexofenadine Product Portfolio

6.13.5 Sumitomo Chemical Recent Developments/Updates

6.14 Panchsheel

6.14.1 Panchsheel Company Information

6.14.2 Panchsheel Description and Business Overview

6.14.3 Panchsheel Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Panchsheel Fexofenadine Product Portfolio

6.14.5 Panchsheel Recent Developments/Updates

6.15 CAMEO HEALTH CARE

6.15.1 CAMEO HEALTH CARE Company Information

6.15.2 CAMEO HEALTH CARE Description and Business Overview

6.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.15.4 CAMEO HEALTH CARE Fexofenadine Product Portfolio

6.15.5 CAMEO HEALTH CARE Recent Developments/Updates

6.16 CEPiA-Sanofi

6.16.1 CEPiA-Sanofi Company Information

6.16.2 CEPiA-Sanofi Description and Business Overview

6.16.3 CEPiA-Sanofi Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.16.4 CEPiA-Sanofi Fexofenadine Product Portfolio

6.16.5 CEPiA-Sanofi Recent Developments/Updates

6.17 Va Sudha Pharma Chem Limited

6.17.1 Va Sudha Pharma Chem Limited Company Information

6.17.2 Va Sudha Pharma Chem Limited Description and Business Overview

6.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Va Sudha Pharma Chem Limited Fexofenadine Product Portfolio

6.17.5 Va Sudha Pharma Chem Limited Recent Developments/Updates

6.18 VPL Chemicals

6.18.1 VPL Chemicals Company Information

6.18.2 VPL Chemicals Description and Business Overview

6.18.3 VPL Chemicals Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.18.4 VPL Chemicals Fexofenadine Product Portfolio

6.18.5 VPL Chemicals Recent Developments/Updates

6.19 Zhejiang Excel Pharmaceutical

6.19.1 Zhejiang Excel Pharmaceutical Company Information

6.19.2 Zhejiang Excel Pharmaceutical Description and Business Overview

6.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Zhejiang Excel Pharmaceutical Fexofenadine Product Portfolio

6.19.5 Zhejiang Excel Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Fexofenadine Industry Chain Analysis

7.2 Fexofenadine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Fexofenadine Production Mode & Process Analysis

7.4 Fexofenadine Sales and Marketing

7.4.1 Fexofenadine Sales Channels

7.4.2 Fexofenadine Distributors

7.5 Fexofenadine Customer Analysis

8 Fexofenadine Market Dynamics

8.1 Fexofenadine Industry Trends

8.2 Fexofenadine Market Drivers

8.3 Fexofenadine Market Challenges

8.4 Fexofenadine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Viruj Pharma

Cemex Pharma

Smaart Pharmaceutticals

Admiron Life Sciences Private Limited

Va Sudha Pharma Chem Limited

VPL Chemicals

Zhejiang Excel Pharmaceutical

List of Tables

Table 1. Global Fexofenadine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Fexofenadine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Fexofenadine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Fexofenadine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Fexofenadine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Fexofenadine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Fexofenadine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Fexofenadine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Fexofenadine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Fexofenadine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Fexofenadine, Product Type & Application

Table 12. Global Key Manufacturers of Fexofenadine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Fexofenadine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fexofenadine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Fexofenadine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Fexofenadine Sales by Region (2020-2025) & (K Units)

Table 18. Global Fexofenadine Sales Market Share by Region (2020-2025)

Table 19. Global Fexofenadine Sales by Region (2026-2031) & (K Units)

Table 20. Global Fexofenadine Sales Market Share by Region (2026-2031)

Table 21. Global Fexofenadine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Fexofenadine Revenue Market Share by Region (2020-2025)

Table 23. Global Fexofenadine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Fexofenadine Revenue Market Share by Region (2026-2031)

Table 25. North America Fexofenadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Fexofenadine Sales by Country (2020-2025) & (K Units)

Table 27. North America Fexofenadine Sales by Country (2026-2031) & (K Units)

Table 28. North America Fexofenadine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Fexofenadine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Fexofenadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Fexofenadine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Fexofenadine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Fexofenadine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Fexofenadine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Fexofenadine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Fexofenadine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Fexofenadine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Fexofenadine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Fexofenadine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Fexofenadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Fexofenadine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Fexofenadine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Fexofenadine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Fexofenadine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Fexofenadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Fexofenadine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Fexofenadine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Fexofenadine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Fexofenadine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Fexofenadine Sales (K Units) by Type (2020-2025)

Table 51. Global Fexofenadine Sales (K Units) by Type (2026-2031)

Table 52. Global Fexofenadine Sales Market Share by Type (2020-2025)

Table 53. Global Fexofenadine Sales Market Share by Type (2026-2031)

Table 54. Global Fexofenadine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Fexofenadine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Fexofenadine Revenue Market Share by Type (2020-2025)

Table 57. Global Fexofenadine Revenue Market Share by Type (2026-2031)

Table 58. Global Fexofenadine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Fexofenadine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Fexofenadine Sales (K Units) by Application (2020-2025)

Table 61. Global Fexofenadine Sales (K Units) by Application (2026-2031)

Table 62. Global Fexofenadine Sales Market Share by Application (2020-2025)

Table 63. Global Fexofenadine Sales Market Share by Application (2026-2031)

Table 64. Global Fexofenadine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Fexofenadine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Fexofenadine Revenue Market Share by Application (2020-2025)

Table 67. Global Fexofenadine Revenue Market Share by Application (2026-2031)

Table 68. Global Fexofenadine Price (USD/Unit) by Application (2020-2025)

Table 69. Global Fexofenadine Price (USD/Unit) by Application (2026-2031)

Table 70. Viruj Pharma Company Information

Table 71. Viruj Pharma Description and Business Overview

Table 72. Viruj Pharma Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Viruj Pharma Fexofenadine Product

Table 74. Viruj Pharma Recent Developments/Updates

Table 75. Cemex Pharma Company Information

Table 76. Cemex Pharma Description and Business Overview

Table 77. Cemex Pharma Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Cemex Pharma Fexofenadine Product

Table 79. Cemex Pharma Recent Developments/Updates

Table 80. Smaart Pharmaceutticals Company Information

Table 81. Smaart Pharmaceutticals Description and Business Overview

Table 82. Smaart Pharmaceutticals Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Smaart Pharmaceutticals Fexofenadine Product

Table 84. Smaart Pharmaceutticals Recent Developments/Updates

Table 85. Titan Pharma Company Information

Table 86. Titan Pharma Description and Business Overview

Table 87. Titan Pharma Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Titan Pharma Fexofenadine Product

Table 89. Titan Pharma Recent Developments/Updates

Table 90. AFCL Company Information

Table 91. AFCL Description and Business Overview

Table 92. AFCL Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. AFCL Fexofenadine Product

Table 94. AFCL Recent Developments/Updates

Table 95. Synkromax Company Information

Table 96. Synkromax Description and Business Overview

Table 97. Synkromax Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Synkromax Fexofenadine Product

Table 99. Synkromax Recent Developments/Updates

Table 100. Farmhispania Company Information

Table 101. Farmhispania Description and Business Overview

Table 102. Farmhispania Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Farmhispania Fexofenadine Product

Table 104. Farmhispania Recent Developments/Updates

Table 105. Gen Pharma Company Information

Table 106. Gen Pharma Description and Business Overview

Table 107. Gen Pharma Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Gen Pharma Fexofenadine Product

Table 109. Gen Pharma Recent Developments/Updates

Table 110. Admiron Life Sciences Private Limited Company Information

Table 111. Admiron Life Sciences Private Limited Description and Business Overview

Table 112. Admiron Life Sciences Private Limited Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Admiron Life Sciences Private Limited Fexofenadine Product

Table 114. Admiron Life Sciences Private Limited Recent Developments/Updates

Table 115. JRC Company Information

Table 116. JRC Description and Business Overview

Table 117. JRC Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. JRC Fexofenadine Product

Table 119. JRC Recent Developments/Updates

Table 120. Archerchem Company Information

Table 121. Archerchem Description and Business Overview

Table 122. Archerchem Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Archerchem Fexofenadine Product

Table 124. Archerchem Recent Developments/Updates

Table 125. Sibram Company Information

Table 126. Sibram Description and Business Overview

Table 127. Sibram Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Sibram Fexofenadine Product

Table 129. Sibram Recent Developments/Updates

Table 130. Sumitomo Chemical Company Information

Table 131. Sumitomo Chemical Description and Business Overview

Table 132. Sumitomo Chemical Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Sumitomo Chemical Fexofenadine Product

Table 134. Sumitomo Chemical Recent Developments/Updates

Table 135. Panchsheel Company Information

Table 136. Panchsheel Description and Business Overview

Table 137. Panchsheel Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Panchsheel Fexofenadine Product

Table 139. Panchsheel Recent Developments/Updates

Table 140. CAMEO HEALTH CARE Company Information

Table 141. CAMEO HEALTH CARE Description and Business Overview

Table 142. CAMEO HEALTH CARE Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. CAMEO HEALTH CARE Fexofenadine Product

Table 144. CAMEO HEALTH CARE Recent Developments/Updates

Table 145. CEPiA-Sanofi Company Information

Table 146. CEPiA-Sanofi Description and Business Overview

Table 147. CEPiA-Sanofi Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. CEPiA-Sanofi Fexofenadine Product

Table 149. CEPiA-Sanofi Recent Developments/Updates

Table 150. Va Sudha Pharma Chem Limited Company Information

Table 151. Va Sudha Pharma Chem Limited Description and Business Overview

Table 152. Va Sudha Pharma Chem Limited Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Va Sudha Pharma Chem Limited Fexofenadine Product

Table 154. Va Sudha Pharma Chem Limited Recent Developments/Updates

Table 155. VPL Chemicals Company Information

Table 156. VPL Chemicals Description and Business Overview

Table 157. VPL Chemicals Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. VPL Chemicals Fexofenadine Product

Table 159. VPL Chemicals Recent Developments/Updates

Table 160. Zhejiang Excel Pharmaceutical Company Information

Table 161. Zhejiang Excel Pharmaceutical Description and Business Overview

Table 162. Zhejiang Excel Pharmaceutical Fexofenadine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 163. Zhejiang Excel Pharmaceutical Fexofenadine Product

Table 164. Zhejiang Excel Pharmaceutical Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Fexofenadine Distributors List

Table 168. Fexofenadine Customers List

Table 169. Fexofenadine Market Trends

Table 170. Fexofenadine Market Drivers

Table 171. Fexofenadine Market Challenges

Table 172. Fexofenadine Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Fexofenadine

Figure 2. Global Fexofenadine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fexofenadine Market Share by Type: 2024 & 2031

Figure 4. Purity:98% Product Picture

Figure 5. Purity:Above 98% Product Picture

Figure 6. Global Fexofenadine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Fexofenadine Market Share by Application: 2024 & 2031

Figure 8. Hay Fever Treatment

Figure 9. Urticaria Treatment

Figure 10. Global Fexofenadine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Fexofenadine Market Size (2020-2031) & (US$ Million)

Figure 12. Global Fexofenadine Sales (2020-2031) & (K Units)

Figure 13. Global Fexofenadine Average Price (USD/Unit) & (2020-2031)

Figure 14. Fexofenadine Report Years Considered

Figure 15. Fexofenadine Sales Share by Manufacturers in 2024

Figure 16. Global Fexofenadine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Fexofenadine Players: Market Share by Revenue in Fexofenadine in 2024

Figure 18. Fexofenadine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Fexofenadine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Fexofenadine Sales Market Share by Country (2020-2031)

Figure 21. North America Fexofenadine Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Fexofenadine Sales Market Share by Country (2020-2031)

Figure 25. Europe Fexofenadine Revenue Market Share by Country (2020-2031)

Figure 26. Germany Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Fexofenadine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Fexofenadine Revenue Market Share by Region (2020-2031)

Figure 33. China Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Fexofenadine Sales Market Share by Country (2020-2031)

Figure 43. Latin America Fexofenadine Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Fexofenadine Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Fexofenadine Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Fexofenadine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Fexofenadine by Type (2020-2031)

Figure 53. Global Revenue Market Share of Fexofenadine by Type (2020-2031)

Figure 54. Global Fexofenadine Price (USD/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Fexofenadine by Application (2020-2031)

Figure 56. Global Revenue Market Share of Fexofenadine by Application (2020-2031)

Figure 57. Global Fexofenadine Price (USD/Unit) by Application (2020-2031)

Figure 58. Fexofenadine Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions